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Abstract 29 
Background 30 
Patients with chronic kidney disease treated by haemodialysis (HD) are 31 
at increased risk of sarcopenia. Bioelectrical impedance spectroscopy (BIS) can 32 
be used to determine body composition, and is one of several potential screening 33 
tools for sarcopenia. The newer generation of portable hand held devices can be 34 
readily used in dialysis centres. The results from BIS devices using a two 35 
compartmental model of body composition can be affected by hydration status 36 
  
2 
and so ideally measurements should be made when patients are not 37 
overhydrated. More recently BIS devices using a three compartmental body 38 
model, which separate normally hydrated lean tissues from extracellular water 39 
(ECW) excess. We wished to determine whether body composition measured 40 
using such a BIS device was affected by hydration status. 41 
Methods 42 
We performed BISs pre and post-haemodialysis using a three body 43 
compartmental model .  44 
Results 45 
BISs were recorded in 48 patients; 68.8% male; mean age 67.70±14.21 46 
years, weight pre dialysis 70.54±18.07, which fell post to 68.58±17.78 kg, 47 
Extracellular water fell (16.92±4.76 vs 15.66±4.43 L, p<0.001), whereas there 48 
was no change for intracellular water (14.84±4.27 vs 14.90±4.68 L).Fat free mass 49 
index (FFMI) fell (7.87±3.98 vs 16.78±3.97 kg/m2, p<0.001), whereas fat mass 50 
index(FMI)  increased from (7.87±3.98 vs 8.12±3.81 kg/m2, p=0.002). A fall in 51 
FFMI was associated with an increase in FMI (r=0.804, p<0.001). 52 
Conclusion 53 
FMI and FFMI measured by BIA are both confounded by hydration 54 
status. Although pre-dialysis measurements are more convenient, we suggest 55 
BIS should preferably be performed post-dialysis when patients are less over-56 
hydrated and have less electrolyte imbalances. 57 
 58 
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Introduction 76 
 Patients with chronic kidney disease (CKD) at increased risk of 77 
sarcopenia, and once sarcopenia has developed then patients are at increased 78 
risk for mortality. Muscle mass can be determined from anthropomorphic 79 
measurements and muscle wasting assessed as part of the subjective global 80 
assessment (SGA) [1]. However these methods are relatively insensitive in 81 
detecting early changes, observer dependent, and potentially time consuming. As 82 
such other screening tests including dual energy X ray absorptiometry (DXA) 83 
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and bioelectrical impedance assessment (BIA) have been recommended as 84 
alternatives [2,3]. 85 
 DXA scanning and most bioimpedance devices divide the body into 2 86 
compartments; fat mass and fat free mass [4]. Previous reports have 87 
demonstrated a strong correlation between body composition as assessed by 88 
multi-frequency BIA and DXA scanning in dialysis patients [5,6]. However BIA 89 
assessments of body hydration status and body composition can be affected by 90 
localised fluid, such as ascites and intra-peritoneal fluid [7,8], and also by over 91 
hydration [9]. Haemodialysis patients gain fluid between dialysis sessions, and 92 
then this excess fluid is removed during the haemodialysis session. This 93 
relatively rapid change in body fluid following dialysis has been demonstrated to 94 
lead to a change in body composition as determined by BIA [10]. As such BIA 95 
should preferably be made when the haemodialysis patient is closest to their 96 
dry or target weight and not pre-dialysis when they are volume overloaded.  97 
 In clinical practice it is much more convenient to make BIAs prior to the 98 
haemodialysis session, rather than asking patients to remain behind for BIAs. 99 
More recently BIS devices using 3 compartmental body composition models have 100 
been developed [11]. These devices determine the normally hydrated lean body 101 
mass, and as such should not be affected by the changes in hydration that occur 102 
with haemodialysis. We therefore decided to review body composition data from 103 
patients who had corresponding pre and post haemodialysis BIS to determine 104 
whether there were no changes in body composition with dialysis, so that pre-105 
dialysis measurements of body composition alone would suffice. 106 
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 107 
Methods 108 
 We audited the results of body composition estimations taken pre and 109 
post haemodialysis using bioimpedance spectroscopy (BodyStat multiscan 5000 110 
,BodyStat, Douglas, Isle of Man). Four electrodes were placed according to the 111 
manufacturer’s instructions on the dorsal surface of the contra-lateral hand and 112 
foot and ankle to the arterio-venous fistula or arterio-venous graft. Patients 113 
were weighed and height recorded prior to dialysis (Marsden Weighing Group, 114 
Rotherham, UK). Pre dialysis measurements were made with patients lying supine 115 
on a bed. Patients dialysed using Fresenius 4008H (Fresenius Bad Homberg, 116 
Germany) or Dialogue R+ (BBraun, Melsungen, Germany) with high flux 117 
polysulfone dialyzers (Elisio, Nipro Corporation, Osaka, Japan) [12] and 118 
anticoagulated with bolus low molecular weight heparin (Tinzaparin, Leo 119 
Laboratories, Hurley, Berkshire, UK) [13]. Dialysis machines were regularly 120 
serviced and dialysate conductivity checked against flame photometry [14]. We 121 
audited 48 consecutive patients attending for haemodialysis with corresponding 122 
pre and post dialysis measurements.  Patients were not allowed to eat during 123 
dialysis and were restricted to one small drink (180 ml).  After the 124 
haemodialysis session had been completed and the fistula needle sites had 125 
stopped bleeding, then patients were reweighed using the same scales, returned 126 
to lying supine on their bed, rested and then post dialysis measurements were 127 
repeated. There was no change in the position of the electrodes between 128 
measurements. 129 
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Ethics 131 
Standard of care for haemodialysis patients at the Royal Free Hospital 132 
has been to measure bioimpedance pre and post dialysis sessions. We audited 133 
the results of pre and post haemodialysis BIS measurements to determine 134 
whether bioimpedance derived body composition should be measured pre or post 135 
dialysis to be the standard of care for routine clinical practice. Ethical approval 136 
fulfilled UK NHS clinical service development and audit (UK NHS guidelines for 137 
clinical audit and service development (http://www.hra.nhs.uk/documents 138 
/2013/09/ defining-research.pdf)) with all patient data being anonymised.  139 
 140 
Statistical methods 141 
Statistical analysis was by parametric or non-parametric pair testing by 142 
Student’s t test or Mann Whitney U test, and Anova. Univariate correlation was 143 
by Pearson or Spearman correlation (Prism 6.0, Graph Pad, San Diego, USA), and 144 
Bland Altman analysis (version 3.0, Analyse It, Leeds, UK), with significance at 145 
the p<0.05 level. Data is reported as mean ± standard deviation, median and 146 
interquartile range or percentage. 147 
 148 
Results 149 
BIS was measured pre and post-dialysis in 48 patients; 68.8% male; mean 150 
age 67.70±14.21 years (mean ± standard deviation), attending for in-centre 151 
haemodialysis treatments.  Median urine output was <50 (<50-58) ml/day, Stoke-152 
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Davies co-morbidity grade 1 (0-1), and Canadian Society of Geriatrics frailty 153 
score 4 (4-5.8). Fourteen patients had diabetic nephropathy, 13 undetermined 154 
cause, 5 interstitial renal diseases, 4 hypertensive nephropathy, 4 primary 155 
glomerular disease, 3 myeloma kidney, 2 systemic lupus erythematosus, one each 156 
of haemolytic uraemic syndrome, pre-eclampsia, and amyloid. All patients were 157 
prescribed folic acid and B vitamin supplements, and 50% of patients were 158 
additionally prescribed anti-hypertensive medications and 22% diuretics.  159 
Mean weight pre dialysis was 70.54±18.07 kg, height 165.80 ±11.34 cm, 160 
and body mass index (BMI) was 25.52 ±6.11 kg/m2.  161 
 The median dialysis session time was 4.0 (3.5-4) hours, dialysate 162 
temperature 35 (35-35.5)0C, sodium 137 (136-138) mmol/l, potassium 2.0 (1.0-163 
2.0) mmol/l, calcium 1.35 (1.25-1.35) mmol/l, magnesium 0.5 mmol/l, bicarbonate 164 
32 mmol/l, acetate 3.0 mmol/l.  165 
Weight fell post dialysis, as did extracellular water (ECW), but there was 166 
no overall significant change in intracellular water (ICW) (Table 1). Assessments 167 
of body composition showed an increase in measurements for body fat and a fall 168 
in fat free tissues (table 1). As changes in ECW and ICW lead to corresponding 169 
changes in BIS derived body composition, we then looked for differences at the 170 
individual patient level, by Bland Altman analysis comparing the differences 171 
between corresponding pre and post-dialysis values 172 
There was an overall negative mean bias for ICW (Figure 1), suggesting a 173 
small increase in ICW following dialysis and a positive bias for ECW (Figure 2) 174 
showing a loss of ECW. As such there was a mean negative bias for fat mass 175 
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index (FMI) of -0.23 (95% limits of agreement -1.16 to 0.71 kg) corresponding to 176 
an increase in FMI post-dialysis, and a mean positive bias for fat free mass 177 
index (FFMI) of 0.83 (-0.4 to 1.79), with a loss of FFMI post-dialysis. The 178 
corresponding coefficient of variation for FMI and FFMI were 0.49 and 0.24 179 
respectively. 180 
There were positive correlations between the change in pre and post 181 
dialysis ICW and the change in fat free mass (r= 0.29, p=0.042) and muscle mass 182 
(r=0.31, p=0.031), and a negative correlation with the change in fat mass (r=-183 
0.30, p=0.037)). There were positive correlations between the change in pre and 184 
post dialysis ECW and change in fat free mass (r=0.95, p<0.001), muscle mass 185 
(Figure 3) lean dry mass (r=0.37, p=0.01) and a negative correlation with fat 186 
weight (r= 0.78,p<0.001). There was a strong correlation between the change in 187 
muscle mass and fat mass (r=0.82, p<0.001) (Figure 4). 188 
To ensure that patients had re-equilibrated post-dialysis, and that 189 
measurements did not change following dialysis, two additional BIS 190 
measurements were made post-dialysis . There were no significant differences 191 
between 1st, 2nd or 3rd post-dialysis measurements (table 2). 192 
 193 
Discussion 194 
BIA devices have advanced from single frequency to multiple frequency 195 
and bio-impedance spectroscopy (BIS) devices [15] with measurements 196 
comparable to isotopic methods [16]. Standard BIA devices use a 2 197 
compartmental model of body composition, dividing the body into fat and fat 198 
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free mass. However this approach is affected by hydration status, and as muscle 199 
contains more water than fat, when over hydrated then muscle mass is over 200 
estimated [9,10,17]. As such we made measurements with a BIS device using a 3 201 
compartmental model approach which aims to distinguish normally hydrated 202 
muscle mass from pathologic fluid overload when assessing body composition 203 
[11]. This is based on comparing measured ECW and that estimated using the 204 
slope of ECW volume and body weight at normovolaemia, where the slope is 205 
0.239 L/kg for men and 0.214 L/kg for women [11]. As such these bioimpedance 206 
devices potentially have the advantage of being able to assess body composition 207 
using a single pre-dialysis measurement, as there should be no change in fat free 208 
index or fat index with dialysis, whereas standard  bioimpedance devices using a 209 
2 compartment model require post-dialysis measurements to prevent errors due 210 
to hydration status [10].  211 
We observed that whereas both weight and ECW fell post dialysis there 212 
was no significant change in ICW. Associated with weight loss there were 213 
changes in body composition following haemodialysis, with a fall in fat free mass, 214 
muscle and dry lean tissue, and an increase in fat mass. The changes in muscle 215 
mass we observed are in keeping with an earlier version of the BodyStat [18], 216 
but differ from studies using other manufacturers 3 compartmental BIS 217 
devices [18]. When we looked at the individual patient basis, then the greater 218 
the fall in ECW, there was a corresponding greater fall in fat free mass and 219 
muscle mass, but with a negative correlation with fat mass. We observed that a 220 
fall in ICW following haemodialysis was associated with a reduction in muscle 221 
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mass, whereas a gain in ICW was associated with an increase in muscle mass, 222 
which is in keeping with studies using 3 compartmental BIS devices from 223 
different manufacturers [18].  224 
So in keeping with other 2 and 3 compartmental BIA and BIS models this 225 
device over estimated muscle mass and under estimated fat mass pre dialysis 226 
compared to post dialysis values. As such despite a model designed to separate 227 
ECW excess from normo-hydrated fat free tissues this model was affected by 228 
over hydration. This may not be surprising as these models use predictive 229 
models based on ECW relative to ICW, and the relative increase in ECW and 230 
ICW between dialysis sessions varies between patients due to differences in 231 
sodium and water gains. In addition, previous reports have suggested that BIA 232 
measurements can also be affected by body temperature, electrolyte 233 
imbalances, and haematocrit [19]. 234 
Previous studies of patient pre dialysis, when patients were over 235 
hydrated, showed that the BIS over estimated total body skeletal muscle mass 236 
compared to magnetic resonance in patients with lower muscle mass and 237 
conversely under estimated total body skeletal muscle mass in those patients 238 
with greater muscle mass [20]. These differences may be due to errors in 239 
estimating normo-hydrated fat free tissue [11], as muscle in dialysis patients 240 
may not simply just contain more water pre dialysis, but also urea and other 241 
azotaemic toxins, and more recently studies have additionally reported higher 242 
sodium content, and that sodium can be removed from tissue stores during a 243 
haemodialysis session [21].  244 
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Following a haemodialysis session there is redistribution of urea and 245 
other electrolytes, and fluid, which tends to be greater with faster blood flows 246 
[22]. To overcome this rebound phenomenon, dialysis adequacy studies based on 247 
changes in serum urea concentrations advocate taking a delayed post dialysis 248 
serum urea sample to overcome this effect [23]. It is therefore important that 249 
BIS is performed after re-equilibration [24,25]. We waited for fistula needle 250 
sites to have stopped bleeding, and then re-weighed patients, waited for 251 
patients to return to their beds, resume the supine posture, allowed additional 252 
time for the postural change and then performed BISs [26]. We then repeated 253 
BISs to ensure that there were no discernible changes to establish that 254 
patients were in a stable state post dialysis. 255 
Patients with chronic kidney disease are at increased risk of sarcopenia, 256 
and portable hand held BIS devices could be used to screen patients for 257 
sarcopenia [2]. Although there are different classifications for defining 258 
sarcopenia, many simply use a cut-off point of more than 2 standard deviations 259 
from the normal healthy adult lean body mass index. As such, there could 260 
potentially be a difference in the number of patients being classified with 261 
sarcopenia depending upon whether BIS is measured pre or post haemodialysis, 262 
with fewer patients being recorded as having sarcopenia when using pre-dialysis 263 
compared to post dialysis estimations.  264 
Bioimpedance measurements are dependent upon the length of the circuit 265 
and the cross sectional area. As such, moving the electrode placements changes 266 
the results, so one advantage of the Multiscan 5000 was that the larger 267 
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electrodes remained in position during dialysis, and no electrodes had to be 268 
replaced. However this device measures whole body fluid volumes and body 269 
composition using paired ipsi-lateral hand and foot electrodes, with the 270 
assumption that patients are symmetrical. However dialysis patients may be 271 
asymmetrical due to amputations, previous deep venous thrombosis, or central 272 
venous occlusion, stroke, polio etc.  273 
 Most haemodialysis patients are over hydrated and following a 274 
haemodialysis session there are changes in ICW and ECW [27,28]. Despite using 275 
a BIS device based on a 3 compartmental body model, there were still changes in 276 
body composition associated with over hydration. So although pre dialysis BIA 277 
measurements are more convenient to both patients and dialysis centre staff, 278 
for greater reliability BIS measurements should preferably be made when a are 279 
closest to their normo-hydrated state to reduce errors in estimation of body 280 
composition when patients are over hydrated. 281 
 282 
 283 
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 413 
Figure 1. Bland Altman analysis comparing pre haemodialysis intracellular water 414 
(ICW) and post haemodialysis ICW in litres. Mean bias -0.23, 95% limits of 415 
agreement -1.16 to 0.71 L. 416 
 417 
 418 
Figure 2. Bland Altman analysis comparing pre haemodialysis extracellular water 419 
(ECW) and post haemodialysis ECW in litres. Mean bias 0.83, 95% limits of 420 
agreement -0.39 to 2.83 L. 421 
 422 
 423 
Figure 3. Change in intracellular water (ECW) pre and post-dialysis, comparing 424 
with the change muscle mass. Pearson correlation. 425 
 426 
 427 
Figure 4. Change in fat free mass and fat mass following a haemodialysis session. 428 
Pearson correlation. 429 
 430 
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